{{Rsnum
|rsid=10519203
|Gene=AGPHD1
|Chromosome=15
|position=78521704
|Orientation=plus
|GMAF=0.2521
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=HYKK
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 37.2 | 45.1 | 17.7
| HCB | 82.5 | 17.5 | 0.0
| JPT | 85.8 | 14.2 | 0.0
| YRI | 52.4 | 39.5 | 8.2
| ASW | 52.6 | 38.6 | 8.8
| CHB | 82.5 | 17.5 | 0.0
| CHD | 80.7 | 19.3 | 0.0
| GIH | 59.4 | 34.7 | 5.9
| LWK | 54.5 | 37.3 | 8.2
| MEX | 58.6 | 36.2 | 5.2
| MKK | 45.5 | 41.7 | 12.8
| TSI | 30.4 | 52.0 | 17.6
| HapMapRevision=28
}}{{PMID Auto
|PMID=20554942
|Title=Nicotinic Acetylcholine Receptor Region on Chromosome 15q25 and Lung Cancer Risk Among African Americans: A Case-Control Study
|OA=1
}}

{{PMID Auto
|PMID=18759969
|Title=In search of causal variants: refining disease association signals using cross-population contrasts.
|OA=1
}}

{{PMID Auto
|PMID=19706762
|Title=The CHRNA5-CHRNA3-CHRNB4 nicotinic receptor subunit gene cluster affects risk for nicotine dependence in African-Americans and in European-Americans.
|OA=1
}}

{{PMID Auto
|PMID=23454887
|Title=Role of selected genetic variants in lung cancer risk in African Americans.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}